Discovery Value Fund’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-97,976	Closed	-$881K	–	2
2025 Q4	$881K	Sell	97,976 -130,725	-57%	-$1.8M	2.35%	2
2025 Q3	$3.95M	Hold	228,701	–	–	7.05%	3
2025 Q2	$2.15M	Sell	228,701 -332,860	-59%	-$2.73M	4.16%	3
2025 Q1	$3.99M	Hold	561,561	–	–	5.66%	3
2024 Q4	$6.55M	Hold	561,561	–	–	3.76%	4
2024 Q3	$11.5M	Hold	561,561	–	–	5.93%	3
2024 Q2	$12.6M	Hold	561,561	–	–	6.39%	3
2024 Q1	$15.4M	Hold	561,561	–	–	5.35%	4
2023 Q4	$17.1M	Hold	561,561	–	–	7.82%	2
2023 Q3	$17.8M	Hold	561,561	–	–	9.73%	3
2023 Q2	$22.9M	Hold	561,561	–	–	11.62%	3
2023 Q1	$20.9M	Sell	561,561 -11,389	-2%	-$447K	10.54%	3
2022 Q4	$20M	Sell	572,950 -11,533	-2%	-$548K	5.79%	5
2022 Q3	$32.7M	Hold	584,483	–	–	8.21%	4
2022 Q2	$30.3M	Sell	584,483 -401,690	-41%	-$20.4M	6.33%	5
2022 Q1	$71.7M	Sell	986,173 -4,579	-0.5%	-$388K	5.28%	7
2021 Q4	$117M	Buy	990,752 +68,341	+7%	+$8.56M	4.31%	6
2021 Q3	$124M	Sell	922,411 -7,258	-0.8%	-$1.1M	3.63%	6
2021 Q2	$151M	Buy	929,669 +783,179	+535%	+$61M	4.08%	7
2021 Q1	$11.8M	Buy	+146,490	New	+$9.83M	0.38%	13